Clinical Trials Directory

Trials / Sponsors / Nippon Kayaku Co., Ltd.

Nippon Kayaku Co., Ltd.

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Phase III Study of NK105 in Patients With Breast Cancer
Breast Cancer Nos Metastatic Recurrent
Phase 32012-07-01
TerminatedSingle Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC)
Bladder Cancer
Phase 2 / Phase 32011-11-01
CompletedStudy of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
Advanced Solid Tumors, Metastatic Colorectal Cancer
Phase 12010-08-01
CompletedStudy of NK012 and Carboplatin in Solid Tumors With Dose Expansion in Triple Negative Breast Cancer
Advanced Solid Tumors, Metastatic Triple Negative Breast Cancer
Phase 12010-07-01
CompletedA Study of NK012 in Patients With Relapsed Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 22009-07-01
TerminatedEfficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection
Chronic Rejection
N/A2009-06-01
CompletedA Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
Triple Negative Breast Cancer
Phase 22009-02-01
CompletedStudy of NK012 in Patients With Refractory Solid Tumors
Cancer
Phase 12007-03-01
CompletedClinical Pharmacological Study of GnRH Antagonist, Cetrorelix for Healthy Female Volunteer
Premenopause
N/A2006-04-01
CompletedPhase II Study on Gusperimus in Patients With Refractory Wegener's Granulomatosis
Wegener's Granulomatosis
Phase 22003-12-01
CompletedSafety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis
Lupus Nephritis
Phase 1 / Phase 22003-10-01